News

Latest Sylics news about research and events

Cognitive deficits in a mouse model of traumatic brain injury

Using AHCODA and the CognitionWall, the teams at University of Missouri School of Medicine have detected deficits in a military-relevant mouse model of mild blast-induced traumatic brain injury. Using a ...

Anniversary: Serving our clients for 15 years

Sylics was founded in February 2007, as spin-off company of the VU University in Amsterdam. In the first few years, Sylics performed behavioural screening of new mouse mutants in several ...

Sylics’ new website online

The portfolio of mouse models and CRO services of Sylics has grown over the last decade. To accomodate this expansion we have updated our website. This should help our clients ...

Review: Measuring behavior in the Home Cage

In this review in Frontiers in Behavioral Neuroscience, a diverse team of neuroscientists including Sylics' researchers and share their experiences using such an automated monitoring system that combines Noldus PhenoTyper® ...

Sylics starts-up a new location to expand our services and to support your CNS disease research

The ongoing COVID-19 pandemic and again rising infection numbers is affecting all of us personally and our businesses. In this situation, Sylics is focused to continue and expand our support ...

Sylics stands for efficient and high quality drug screening

Tight timelines? Are you in need to have a drug screening study finished before the end of the year to comply with deadlines or your annual budget? At Sylics, we ...

Relevant autism and mental retardation related changes in the Fmr1 knockout mouse

In humans, the absence of the FMR1 protein leads to Fragile X syndrome, mental retardation and neurodevelopmental delays. The Fmr1 knockout mouse model is perceived as highly translational relevant due to the ...

The 22q11 mouse model available at Sylics shows robust Schizophrenia-relevant deficits

Sylics characterized an accepted model in the field of schizophrenia research based on a microdeletion in the orthologous human 22q11.2 locus. In humans, a microdeletion of the 22q11.2 locus leads ...

Sylics is comitted to support CNS disease research, also during these challenging times

The outbreak of COVID-19 affects all of us worldwide in an unprecedented manner. This requires us all to prioritize care and take disruptive measures to stop spread of the virus. ...

Mouse models: Alzheimer’s disease and seeding of tau pathology

An Alzheimer’s Disease mouse model induced by ‘seeding’ of tau pathology may more closely mimic human tau pathology in comparison to transgenic tauopathy mouse models that overexpress human tau with ...